The prevalence of peanut allergy is increasing rapidly and many children are now prescribed selfinjectable epinephrine as part of their management. We aimed to examine the current extent of self-injectable epinephrine dispensing to children in the Eastern Health and Social Services Board (EHSSB), Northern Ireland, including indications for prescription, investigations performed, information and training provided and actual usage. Dispensing records held by the EHSSB were examined for the period May to August 1998. All general practitioners prescribing 'Epipens' during this period were contacted and asked to identify the patient and provide contact details. Information was gathered using postal questionnaires sent to General Practitioners and parents. A total of 104 'Epipen' prescriptions were dispensed. Thirty-seven (36%) general practitioners responded to the initial questionnaire; of these 36 (35%) were suitable for analysis. Thirty-four parents were then contacted; 28 (82%) returned questionnaires were reviewed. The commonest indication for 'Epipen' prescription was peanut allergy (32 of 36 (89%) general practitioner responses; 25 of 28 (89%) parent responses). Twenty-six (72%) children had been seen by a specialist; all except one had either blood or skin tests. Six of the remaining eight children had no investigations. General practitioners reported 14 (39 %) parents to have basic life support training, compared with six (21 %) parents. Eighteen (64%) parents had been given written information regarding their child's allergy, nine (32 %) had been referred to a dietician and seven (25%) children wore a medical warning bracelet. The Epipen had been used by three children; all three had multiple food allergies. This study has identified a great variability in the management ofchildren with allergy including the need for specialist referral, further investigation, written allergy advice, referral to a dietician and formalised training in basic life support and administration of epinephrine. It suggests a lack of consensus amongst health care professionals as to the best practice in the management of potentially life threatening food allergy and indicates, at least, a need for better multidisciplinary communication.
INTRODUCTION
Food allergy is common in childhood, with a prevalence between 0.3% and 8% 1 GPs were questioned on the indication for the 'Epipen' prescription, either peanut or other specified allergies, who prescribed the 'Epipen' and how many were prescribed for each child. They were also asked to provide information on investigations performed (full blood count (FBC) and differential white cell count (DWCC), total IgE, RAST Specific IgE, skin prick testing and/or oral food challenge) and by whom, and what information was given to parents after the prescription of the Epipen (recognition of allergic reactions, when and how to use the 'Epipen', and basic life support (BLS)). Details of usage of the 'Epipen' were also requested. Finally, GPs were asked to record their perceptions on 'Epipen' prescription and allergies. If contact information and consent to approach the parents was provided, they were contacted in writing and asked to complete and return a short questionnaire.
* Parent Questionnaires
Information obtained from parents included their perception of why the 'Epipen' was prescribed, who prescribed it, investigations undertaken, information and training given in the recognition of allergic reactions, when and how to use the 'Epipen' and BLS. Objective data included the number of 'Epipens' held by each child, where they were kept and use to date. Information on referral to dietician, contact with school, provision ofwritten information and use ofMedical Warning Bracelet was obtained.
RESULTS
A total of 104 'Epipen' prescriptions were dispensed by 104 GPs during the four months of the study. All GPs were contacted and a total of 37 (36%) responded to the questionnaire. Names with other allergies (7, 19%) . Allergies other than peanut (egg protein allergy, anaphylaxis to rabbit fur and a reaction to antibiotics in a child with cystic fibrosis) accounted for three (8%), with no information returned in the final case. The commonest indication for 'Epipen' prescription from parent responses was peanut allergy (25/28, 89%) either singly (20, 71 %) or with other allergies (five 8%). Allergies other than peanut (egg protein, rabbit fur and antibiotic reaction) accounted for the remaining three (11 %). In 23 children, where the GP stated that the indication for the 'Epipen' prescription was for peanut allergy alone, parents reported peanut plus other nut allergies. General practitioners reported that 11 (31Y%) 'Epipens' were prescribed by a consultant paediatrician, eight (22%) by an unspecified hospital consultant eight (22%) by the GP, seven (19%) by a consultant immunologist and two (6%) by an unknown source.
General practitioners reported that a total of 26 (72%) children had at least one investigation performed, more commonly in children referred to a secondary specialist. Nine children (82%) prescribed an 'Epipen' by a consultant paediatrician, six (86%) prescribed by a consultant immunologist and seven (88%) prescribed by an undefined hospital consultant had at least one investigation performed, compared to three children (38%) prescribed an 'Epipen' by their GP. Six children (17%) 
